Video

Expert Discusses Exciting Advances in the MPN Field

Author(s):

Angela Fleischman, M.D., Ph.D.

Angela Fleischman, M.D., Ph.D., is particularly excited for improvements in treating early-stage disease.

Angela Fleischman, M.D., Ph.D., of the University of California, Irvine, discusses exciting advancements in the field of myeloproliferative neoplasms (MPNs).

Fleischman, who was honored as one of CURE’s 2018 MPN Heroes, is particularly interested in advancements for early-stage MPNs. If better treatments could be developed in the earlier setting, it could change the national history of the disease, leading to better outcomes.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Image of two doctors and text.
Related Content
Image of doctor
June 21st 2025

What Patients With Polycythemia Vera Should Know After ASCO 2025

Dr. Joshua K. Sabari Dr. Raajit K. Rampal
Patients with blood cancers like polycythemia vera, a kind of myeloproliferative neoplasm, may benefit in learning more about recent data from ASCO 2025.
Cancer Horizons podcast logo
January 8th 2024

FDA Stops Lung Cancer Trial, CAR-T Cell Therapy Is Cost Effective, Novel Drug Slows Fibrosis

Alex Biese Brielle Benyon
The year 2024 is now underway. After a busy 2023, we’re now looking back at some of the oncology headlines from the new year.
Image of blood cells.
June 11th 2025

Rusfertide Reduces Phlebotomy Need, Improves Quality of Life in Polycythemia Vera

Ryan Scott
Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with polycythemia vera.
LeVar Burton Helping the MPN Community Through Advocacy and Storytelling
December 16th 2021

LeVar Burton Helping the MPN Community Through Advocacy and Storytelling

Jamie Cesanek Darlene Dobkowski, MA
On this episode of the “Cancer Horizons” podcast, LeVar Burton sits down with CURE® to talk about the importance of MPN awareness and the power of storytelling in advocacy.
blood cells.
May 29th 2025

Pelabresib and Rituxan Combo Improves Outcomes in Myelofibrosis

Ryan Scott
A patient and provider share updates on pelabresib plus Rituxan treatment, which met the MANIFEST-2 trial's primary end point for those with myelofibrosis.
Image of blood cells.
May 21st 2025

Evolving Myelofibrosis Treatments Aims to Fill Unmet Needs

Ryan Scott
JAK inhibitors ease symptoms in myelofibrosis, but only stem cell transplant offers a cure; newer drugs aim to fill unmet needs, especially for anemia.